Wild-type PIK3CA colon cancer cells displayed sensitivity to each of the MEK inhibitors; however, the mutant PIK3CA colon cancer cells did not respond to the MEK inhibitors (Fig. 1a and Supplementary Table S1). Here, PIK3CA is linked to malignant colon neoplasm.